CRISPR LTD

Company Registration Number:
14996844 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2024

Period of accounts

Start date: 11 July 2023

End date: 31 July 2024

CRISPR LTD

Contents of the Financial Statements

for the Period Ended 31 July 2024

Balance sheet
Additional notes
Balance sheet notes

CRISPR LTD

Balance sheet

As at 31 July 2024

Notes 13 months to 31 July 2024


£
Fixed assets
Tangible assets: 3 15,117
Total fixed assets: 15,117
Current assets
Cash at bank and in hand: 155
Total current assets: 155
Net current assets (liabilities): 155
Total assets less current liabilities: 15,272
Total net assets (liabilities): 15,272
Capital and reserves
Called up share capital: 2
Profit and loss account: 15,270
Total Shareholders' funds: 15,272

The notes form part of these financial statements

CRISPR LTD

Balance sheet statements

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 1 March 2025
and signed on behalf of the board by:

Name: isaac Street
Status: Director

The notes form part of these financial statements

CRISPR LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CRISPR LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Employees

    13 months to 31 July 2024
    Average number of employees during the period 1

CRISPR LTD

Notes to the Financial Statements

for the Period Ended 31 July 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
Additions 16,417 16,417
Disposals
Revaluations
Transfers
At 31 July 2024 16,417 16,417
Depreciation
Charge for year 1,300 1,300
On disposals
Other adjustments
At 31 July 2024 1,300 1,300
Net book value
At 31 July 2024 15,117 15,117